ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus

NCT01570283 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Viral Infection

Interventions

BIOLOGICAL: Multivirus-specific T cells Dose Level 1
BIOLOGICAL: Multivirus-specific T cells Dose Level 2
BIOLOGICAL: Multivirus-specific T cells Dose Level 3

Sponsor

AlloVir

Collaborators

[object Object]
[object Object]
[object Object]